fig1
From: Advances in the non-invasive assessment of metabolic dysfunction-associated steatotic liver disease
Figure 1. Proposed clinical algorithm for NIT-based risk stratification of MASLD in primary care and hepatology settings. This algorithm is proposed by the authors based on current guideline recommendations[2,33]. FIB-4 thresholds are adjusted for patients aged ≥ 65 years. ELF: Enhanced liver fibrosis; FIB-4: fibrosis-4 index; kPa: kilopascal; LSM: liver stiffness measurement; MASLD: metabolic dysfunction-associated steatotic liver disease; MRE: magnetic resonance elastography; NIT: non-invasive test; VCTE: vibration-controlled transient elastography.
